Evaluation of Mental Health Centers (new model of care) in Ukraine according to the RE- AIM-Framework including the dimensions reach, effectiveness, adoption, implementation, maintenance)
Conditions
Interventions
Current methodology as of 16/01/2026:
We will conduct a mixed method approach guided by the RE-AIM framework assessing the five dimensions reach, effectiveness, adoption, implementation, and mainten
Sponsors
University of Zurich
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Current key inclusion criteria as of 16/01/2026: 1. Providers/health professionals working at the MHCs: We include all providers (all roles and functions) working at the MHC. 2. Provider/health professionals working in the communities where the MHCs are located: Existing cooperation/partnership with MHCs. 3. Patients: 3.1. Adults (age =18 years) who are resident of Ukraine 3.2. Receiving current treatment at the MHC 3.3. One to three sessions received at the MHC for the quantitative assessment; a minimum of 6 weeks of treatment received for the qualitative assessment (interviews) 3.4. Providing informed consent 3.5. Being able to complete assessments (no acute mental health condition including, but not limited to psychosis, alcohol intoxication, dementia) _____ Previous key inclusion criteria: 1. Providers/health professionals working at the MHCs: We include all providers (all roles and functions) working at the MHC. 2. Provider/health professionals working in the communities where the MHCs are located: Existing cooperation/partnership with MHCs. 3. Patients: 3.1. Adults (age =18 years) who are resident of Ukraine 3.2. Receiving current treatment at the MHC 3.3. A minimum of = 2 treatment sessions received at the MHC for the quantitative assessment; a minimum of 6 weeks of treatment received for the qualitative assessment (interviews) 3.4. Providing informed consent 3.5. Being able to complete assessments (no acute mental health condition including, but not limited to psychosis, alcohol intoxication, dementia)
Exclusion criteria
Exclusion criteria: Patients: Patients who cannot be reached on multiple attempts
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome(s) as of 16/01/2026: 1. Reach will be assessed by capturing patient data about the total number, characteristics, and referral sources of patients receiving care at MHCs based on the center record data (secondary analysis). Center records and baseline assessment questionnaire will explore demographic and clinical characteristics of patients compared to those who are not receiving care in the center, using data from the control group (MAP study) as a reference. Patient interviews will be conducted to identify factors that hinder or support access to services. A follow-up assessment is planned to follow the completion of phases 1 and 2 of the evaluation, anticipated to occur within 1 to 2 years. 2. Effectiveness will be assessed through quantitative assessment of patient measuring patient symptoms and severity of specific mental health conditions using self-reported outcome measurements: PTSD by the Posttraumatic Stress Disorder Checklist (PCL-5), depression by the Patient Health Questionnaire 9 (PHQ- 9), anxiety by the Generalized Anxiety Disorder 7 (GAD-7), somatic symptoms by the Patient Health Questionnaire 15 (PHQ-15), alcohol use disorder by the Alcohol Use Disorders Identification Test (AUDIT). Health-related quality of life will be measured by the European Quality of Life 5 Dimensions (EQ-5D-5L) instrument and the visual analogue scale (EQ-VAS) and mental wellbeing by Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS). These assessments take place at baseline, follow-up 1 (after 3 months) and follow-up 2 (after 6 months). 3. Adoption will be evaluated at the MHC- and the community-level. Center records will capture the number, proportion and characteristics of MHCs and their affiliated providers/health professionals. For providers/health professionals working at the MHC, self-reported validated questionnaires will be completed: The Team Development Measure (TDM), the Mental Illness Clinicians’ Attitudes Scale (MICA-4), the Copen | — |
Secondary
| Measure | Time frame |
|---|---|
| Qualitative data and context-specific insights generated in workshops with key stakeholders after each phase of the evaluation was completed to inform about the results of the evaluation and to facilitate improvement in mental health care delivery. | — |
Countries
Ukraine
Contacts
Public ContactMilo Alan Puhan
Outcome results
None listed